LIMNW
NASDAQ
Liminatus Pharma, Inc. - Warrants
$0.06
▲ +$0.00
(+0.00%)
Price Chart
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2025-0… | 2025-0… |
|---|---|---|---|
| Revenue | — | — | — |
| Net Income | -$601K | -$255 | -$1.8M |
Financial Health
Free Cash Flow
-$614K
Net Debt
$718K
Cash
$725K
Total Debt
$1.4M
As of Sep 30, 2025
Top Holders
Top 5: 23.08%Clear Street Group Inc.
10.41%
$33K
Aristeia Capital, LLC
4.13%
$13K
Linden Advisors LP
3.47%
$11K
Saba Capital Management, L.…
3.02%
$10K
Highbridge Capital Manageme…
2.05%
$6K
As of Dec 31, 2025
Latest News
No related news yet